The agency teamed up with the software company to develop platforms and networks to collect de-identified data
@US_FDA Workflow Services
https://t.co/CTXYo8Yx42
DELFI-Tumor Fraction assay was developed to improve noninvasive assessment of tumor burden and monitoring of treatment efficacy and resistance in patients with advanced cancers
https://t.co/5mKrd2E5LS
DELFI-Tumor Fraction assay was developed to improve noninvasive assessment of tumor burden and monitoring of treatment efficacy and resistance in patients with advanced cancers
https://t.co/5mKrd2DxWk
Expanding the use of technology that automates certain tasks will allow #healthcareproviders to do more with less risk of compounding burnout🖋️ Lawrence King, Director, Product Safety & Performance, @Surescripts
https://t.co/wFU7aQjW4Y
#medicaldevices#pharmaceutical
Expanding the use of technology that automates certain tasks will allow #healthcareproviders to do more with less risk of compounding burnout🖋️ Lawrence King, Director, Product Safety & Performance, @Surescripts
https://t.co/wFU7aQjofq
#medicaldevices#pharmaceutical
Expanding the use of technology that automates certain tasks will allow #healthcareproviders to do more with less risk of compounding burnout🖋️ Lawrence King, Director, Product Safety & Performance, @Surescripts
https://t.co/wFU7aQjofq
#medicaldevices#pharmaceutical
The Changing Role of Diagnostic Labs in Personalized Oncology Care
🔸Learn more in this @IQVIA_global article about the changing dynamics of drug and therapy development and the evolving role of diagnostic labs.
Read the article:
https://t.co/3wVAtghK3p
The Changing Role of Diagnostic Labs in Personalized Oncology Care
🔸Learn more in this @IQVIA_global article about the changing dynamics of drug and therapy development and the evolving role of diagnostic labs.
Read the article:
https://t.co/3wVAtghK3p
‼️#VirtualReality – Based Interventions Found to Lower #Anxiety in Patients Prior to Undergoing Surgery‼️
The continued development of more convenient VR technology has improved usability, accessibility, and affordability across healthcare settings
https://t.co/6o6ThDDzxJ
In this Q&A, Andrew Hopkins, founder and CEO of @exscientiaAI reveals how #artificialintelligence (#AI) is currently being utilized in the #pharma industry, predictions for where AI can be implemented in the future, and what pharma fears most about AI💬🗨️
https://t.co/eU3pGSJUuG